Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss
Condition(s):Autoimmune Neurosensory Hearing Loss (ANSHL)Last Updated:September 13, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Autoimmune Neurosensory Hearing Loss (ANSHL)Last Updated:September 13, 2017Unknown status
Condition(s):Cold Contact UrticariaLast Updated:July 17, 2018Completed
Condition(s):Recurrent PericarditisLast Updated:November 23, 2020Active, not recruiting
Condition(s):Subacromial BursitisLast Updated:August 4, 2014Completed
Condition(s):DIRALast Updated:October 16, 2017Completed
Condition(s):Type 1 Diabetes MellitusLast Updated:February 24, 2014Completed
Condition(s):Renal Insufficiency, ChronicLast Updated:September 12, 2016Completed
Condition(s):Scleroderma; Systemic Sclerosis; Diffuse Scleroderma; Diffuse Systemic SclerosisLast Updated:May 1, 2018Completed
Condition(s):Familial Mediterranean FeverLast Updated:February 11, 2013Completed
Condition(s):Muckle-Wells Syndrome; Schnitzler SyndromeLast Updated:May 31, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.